North America Marine Biotechnology Market Size, Share, and Trends 2025 to 2034

The north america marine biotechnology market size is calculated at USD 3.20 billion in 2025 and is forecasted to reach around USD 6.05 billion by 2034, accelerating at a CAGR of 7.34% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

Last Updated : July 2025  |  Report Code : 6315  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on North America Marine Biotechnology Market 

5.1. COVID-19 Landscape: North America Marine Biotechnology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. North America Marine Biotechnology Market, By Source

8.1. North America Marine Biotechnology Market Revenue and Volume, by Source

8.1.1 Corals and sponges

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Algae

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Marine Viruses

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Marine Fungi

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Others

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. North America Marine Biotechnology Market, By Application

9.1. North America Marine Biotechnology Market Revenue and Volume, by Application

9.1.1. Aquaculture & Fishery

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Medicine

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Environment

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Biofuels

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Others

9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. North America Marine Biotechnology Market, By End User

10.1. North America Marine Biotechnology Market Revenue and Volume, by End User

10.1.1. Medical & Pharmaceutical

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Food Industry

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Cosmetics Industry

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Chemical Industry

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. North America Marine Biotechnology Market, and Trend Forecast

11.1. U.S.

11.1.1. Market Revenue and Volume Forecast, by Device Type

11.1.2. Market Revenue and Volume Forecast, by Display Type

11.1.3. Market Revenue and Volume Forecast, by Size

11.1.4. Market Revenue and Volume Forecast, by Display Technology

11.1.5. Market Revenue and Volume Forecast, by End-user

11.1.6.1. Rest of North America

11.1.6.2. Market Revenue and Volume Forecast, by Device Type

11.1.6.3. Market Revenue and Volume Forecast, by Display Type

11.1.6.4. Market Revenue and Volume Forecast, by Size

11.1.6.5. Market Revenue and Volume Forecast, by Display Technology

11.1.6.6. Market Revenue and Volume Forecast, by End-user

Chapter 12. Company Profiles

12.1. Abbott

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Aker Biomarine    

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Biolume Inc

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Cp Kelco

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Cyanotech Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. FMC Geomarine Biotech

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Lonza Group Ltd.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. FMC Health And Nutrition

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Nutrex Hawaii Incorporated

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Phyco Biotech Sas

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The north america marine biotechnology market is expected to increase from USD 2.98 billion in 2024 to USD 6.05 billion by 2034.

The north america marine biotechnology marketis expected to grow at a compound annual growth rate (CAGR) of around 7.34% from 2025 to 2034.

The major players in the north america marine biotechnology market include Abbott, Aker Biomarine, Biolume Inc, Cp Kelco, Cyanotech Corporation, FMC Geomarine Biotech, FMC Health And Nutrition, Lonza Group Ltd., Nutrex Hawaii Incorporated, Phyco Biotech Sas, Qingdao Codo International Ltd, Sea Run Holding, and Seppic Sa.

The driving factors of the north america marine biotechnology market are the growing consumer preference for clean-label, anti-aging skincare is fuelling the use of marine bioactives in premium cosmetic formulations.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client